Features Screener Stocks Charts
Sign In Sign Up

Caplin Point Laboratories Income Statement

NSE:CAPLIPOINT | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year CAPLIPOINT income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 17.61B 20.34B
Cost of Revenue -7.24B -7.71B
Gross Profit 10.37B 12.63B
Sales, General & Admin -4.18B -5.20B
Operating Income 5.65B 6.77B
Profit Before Tax 5.64B 6.77B
Net Income 4.61B 5.41B
Diluted Shares 76.31M 76.35M
Diluted EPS 59.90 70.25

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025